Danaher shares are under pressure Wednesday as the Club holding's fourth-quarter earnings results came in mixed and guidance disappointed. The company long known for its operational excellence is ...

WASHINGTON, July 16, 2024 /PRNewswire/ -- Danaher Corporation (DHR) ("Danaher" or the "Company"), the global life sciences and diagnostics innovator, today published its 2024 Sustainability Report ...

Danaher (DHR) is an American global conglomerate with a strong presence in the life sciences and diagnostics industries. It’s an under-the-radar compounder that has consistently grown over the past ...

Danaher has increased its dividend for 13 consecutive years, and its dividend growth has been nothing short of spectacular.

Shares in biotechnology, life sciences, and diagnostics company Danaher (NYSE: DHR) rose by as much as 12.9% in early morning trading today. The move follows a well-received third-quarter earnings ...

Through its Danaher Business System, Danaher aims for continuous improvement of its scientific technology portfolio by seeking out attractive markets and then making acquisitions to enter or expand ...

We recently upgraded our economic moat rating for Danaher DHR to wide from narrow. An acquisition-focused strategy has helped the company become a key player in scientific instruments and consumables ...

We came across a bullish thesis on Danaher Corporation on Heavy Moat Investments’s Substack. In this article, we will summarize the bulls’ thesis on DHR. Danaher Corporation’s share was trading at ...

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has ...

DEVON, Pa.--(BUSINESS WIRE)--L2 Capital Partners, L.P. (“L2” or “L2 Capital”) (www.L2Capital.net) announced today that it has added former Danaher executive, Lorin Cassidy Wolfe, as Chief Operating ...